Enrollment has begun in the first of two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV infection.
Source: HIV/AIDS news from Medical News Today
streeck
HIV can develop resistance to CRISPR/Cas9
The CRISPR/Cas9 gene-editing platform may need a little bit more tweaking before it can be used as an effective antiviral, reports a study published in Cell Reports.
Source: HIV/AIDS news from Medical News Today
HIV vaccine possibility following study of 'antibodies with loops'
A study of antibodies with a loop-like structure that bind to and disable the virus could lead to a vaccine that rapidly induces broadly neutralizing antibodies against HIV.
Source: HIV/AIDS news from Medical News Today
TSRI scientists get first-ever glimpse of 'teenage' HIV-neutralizing antibody
Scientists at The Scripps Research Institute (TSRI) and collaborating institutions have described the first-ever immature or “teenage” antibody found in a powerful class of immune molecules…
Source: HIV/AIDS news from Medical News Today
HIV-positive children and adolescents: Added benefit of rilpivirine not proven
Drug manufacturer only presented data from a one-arm study and also conducted no indirect comparison.
Source: HIV/AIDS news from Medical News Today
Applying parameter selection and verification techniques to an HIV model
Physical and biological models often have hundreds of inputs, many of which may have a negligible effect on a model’s response.
Source: HIV/AIDS news from Medical News Today
HIV treatment, REZOLSTA (darunavir/cobicistat), gains green light for funding by NHS England
Janssen-Cilag Ltd has announced that NHS England (NHSE) will provide crucial funding for its once-daily, fixed-dose combination of darunavir and the pharmacoenhancer, cobicistat, called…
Source: HIV/AIDS news from Medical News Today
Enzyme may reduce risk of cardiovascular disease caused by HIV medications
According to the World Health Organization, approximately 37 million people are living with HIV. Antiviral medications are used to control the disease and prevent its progression to AIDS.
Source: HIV/AIDS news from Medical News Today
Most individuals harbor B cells sensitive to HIV-fighting immunogen
Researchers have identified a relatively potent immunogen that could be harnessed to induce the immune system to target HIV.
Source: HIV/AIDS news from Medical News Today
More ancient viruses lurk in our DNA than we thought
One whole endogenous retrovirus genome — and bits of 17 others — were spotted in a study of 2,500 human genomes.Think your DNA is all human? Think again.
Source: HIV/AIDS news from Medical News Today